热门资讯> 正文
吉利德股价上涨，提高2024年销售额，非GAAP每股收益前景
2024-11-07 06:48
- 吉利德科学(GILD) 0
- 李尔(LEA) 0
- Gilead Sciences (NASDAQ:GILD) is up ~3% in after-hours trading Wednesday after its Q3 financial results beat on both lines and it raised its 2024 sales and non-GAAP EPS.
- The biotech now sees full-year sales of $27.8B-$28.1B compared to $27.1B-$27.5B prior. Revenue consensus is $27.73B. Non-GAAP diluted EPS is now seen at $4.25-$4.45, up from $3.60-$3.90 prior. Consensus is $3.79.
- On a non-GAAP basis, net income in the quarter fell to ~$2.5B from ~$2.9B in the year-ago period (non-GAAP diluted EPS of $2.02 vs. $2.29).
- Gilead ended the quarter (Sept. 30) with cash, cash equivalents and marketable debt securities of ~$5B compared to $8.4B on Dec. 31, 2023.
More on Gilead Sciences
- Consider Buying Gilead To Benefit From Its Strong Outlook, Favorable Valuation
- Gilead Sciences: My Worst Stock Move In 2024, And What I Learned From It
- Gilead Sciences, Inc. (GILD) Baird Global Healthcare Conference (Transcript)
- Gilead Sciences Non-GAAP EPS of $2.02 beats by $0.47, revenue of $7.55B beats by $550M
- Arcus says Gilead-partnered cancer therapy cut death risk by 36%
推荐文章
美股机会日报 | 金价再度走弱！现失守4030美元；中美贸易争端缓和，纳指期货涨超1%
IBM、AMD双双大涨近8%！量子计算概念再起飞，下一个赢家是谁？
新股暗盘 | 滴普科技涨近50%，中签一手账面浮盈2660港元
新股暗盘 | 八马茶业涨79.00%，中签一手账面浮盈3950港元
美股波动中的稳健长跑选手：华尔街押注Pinterest(PINS.US)、Uber(UBER.US)与通用汽车(GM.US)
黄金火爆行情带热招聘市场 对冲基金、贸易商高薪争夺交易人才
迷雾中前行！美联储本周料将再度降息 内部分歧恐进一步加剧？
新股申购 | “首家A+H豪华新能源车企”赛力斯今起招股，一手入场费13282.62港元
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
